High Grade Brain Tumors clinical trials

Explore recruiting high grade brain tumors clinical trials.

Recruiting high grade brain tumors studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

High Grade Brain Tumors trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

TARLATEM : Combination of TARLAtamab and TEMozolomide in patients with central nervous system tumors. A multicenter, open-label Phase I/II trial aiming to assess the safety and clinical activity of Tarlatamab in combination with metronomic Temozolomide in adolescents and adults’ patients with high grade brain tumors

France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

INTRATUMORAL DNX-2401 ADMINISTRATION FOR RECURRENT AND REFRACTORY HIGH GRADE BRAIN TUMORS IN PEDIATRIC AND YOUNG ADULT PATIENTS

Netherlands, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

High Grade Brain Tumors trials by city

High Grade Brain Tumors clinical trials

Recruiting high grade brain tumors studies right now

5G-PEARL: Paxalisib in Malignant Brain Tumours

Bevacizumab Versus Corticosteroids as First-line Treatment in Patients With Symptomatic Cerebral Radiation Necrosis After Radiation for High-grade Glioma or Brain Metastases

Window of Opportunity Study of DSP-0390 in Gliomas

Injection of Active Allogeneic Natural Killer Cells in Patients With Gliomas

Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.

Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma

Advice of Moderate Drinking Pattern Versus Advice on Abstention on Major Disease and Mortality

A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients

Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies.

Also recruiting in Europe

INTRATUMORAL DNX-2401 ADMINISTRATION FOR RECURRENT AND REFRACTORY HIGH GRADE BRAIN TUMORS IN PEDIATRIC AND YOUNG ADULT PATIENTS

High Grade Brain Tumors trials by city

Other conditions